Dr. Lai is an Integrative Hepatologist who holds the Endowed Professorship of Liver Health & Transplantation at the University of California, San Francisco (UCSF).

Jessica Bartholomew, MSN, APRN, FNP-C, is a hepatology nurse practitioner and sub-investigator in Houston, Texas, focused on MASLD/MASH. She serves as Associate Lead for the AASLD MASLD Special Interest Group and is a member of the Global NASH/MASH Advanced Practice Providers (APP) Committee and GHAPP. She is passionate about advancing APP-led care in liver disease and has contributed to published recommendations guiding MASH management for APPs. Her interests include early detection, noninvasive testing, lifestyle modifications, and the evolving therapeutic pipeline.

Anthony Derencius is a Physician Assistant and Clinical Investigator at Pinnacle Clinical Research in San Antonio, Texas. His work experience includes clinical duties and care in general Gastroenterology, General Hepatology, and Transplant Hepatology in outpatient and inpatient roles. He was selected for a 2018 AASLD Foundation NP/PA Clinical Hepatology Fellowship Award and is an active member of both the Hepatology Associates Committee and Special Interest Group. He has served as the Hepatology Associates Committee Liaison to the Emerging Liver Advanced Practice Provider program.

Dr. Jacqueline O'Leary began her pursuit of research as an undergraduate at Stanford investigating drug development, continued at UCSF where she received and MD with thesis for work in cellular and molecular biology. Following her internal medicine residency at UT Southwestern in Dallas, Dr. O'Leary did a GI fellowship and transplant Hepatology fellowship at Massachusetts General Hospital. Her post-doctoral research there at Harvard focused on immunology. Afterward, she completed a Master's in Public Health from the Harvard School of Public Health.

Dr. Monga is the SVC Endowed Chair in Pathobiology and Therapeutics and Professor of Pharmacology and Medicine at the University of Pittsburgh. He is the Chair/Director of the Organ Pathobiology and Therapeutics Institute. He is also the director of the Pittsburgh Liver Research Center, an NIDDK P30 funded Digestive Disease Research Core Center and the program director of the NIBIB-funded predoctoral training program entitled Cellular Approaches to Tissue Engineering and Regeneration. He serves as the Associate Dean of Research for the University of Pittsburgh School of Medicine.

I am currently Professor and Vice Chair for Research of the Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth). I received my PhD in drug metabolism and toxicology from the University of Toronto, Canada in 1999, followed by postdoctoral training at the National Heart Lung and Blood Institute (NHLBI). I joined the School of Pharmacy, University of Colorado as an Assistant Professor in 2002, and was promote to Associate and Full Professor in 2009 and 2015, respectively.

I am currently a member of the Department of Pharmacology and Toxicology at Michigan State University. My research has focused on the role of hypoxia and hypoxia-inducible factors in liver fibrosis and also on the immunoregulatory properties of bile acids during cholestatic liver disease. More recently my work has focused on elucidating the mechanisms that drive the transition from severe acute liver injury to acute liver failure.

Dr. Carmen Chak-Lui Wong is currently a Professor and Principal Investigator in the Department of Pathology and State Key Laboratory of Liver Research at the University of Hong Kong (HKU). She is currently the Assistant Dean of the LKS Faculty of Medicine at HKU. She is the program leader of the liver cancer program at Center of Oncology and Immunology at InnoHealth, Hong Kong.

Dr McLin is the Medical Director of the Swiss Pediatric Liver Center, and the Head of the Unit of Gastroenterology, Hepatology, and Nutrition at University Hospitals Geneva in Switzerland. She is the Principal Investigator of the International Registry of Congenital Portosystemic Shunts (www.ircpss.com).